HCTI vs HCAT

For growth investors, Health Catalyst, Inc.

(HCAT) is the stronger pick with 1. 5% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Analysts rate Health Catalyst, Inc. (HCAT) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Health Catalyst, Inc.

(HCAT) delivered a total return of -97. 0%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: HCAT returned -95. 9% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Health Catalyst, Inc.

(HCAT) is the lower-risk stock at 2. 05β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 50% more volatile than HCAT relative to the S&P 500.

By revenue growth (latest reported year), Health Catalyst, Inc.

(HCAT) is pulling ahead at 1. 5% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to -121. 7% for Health Catalyst, Inc.. Over a 3-year CAGR, HCAT leads at 4. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Healthcare Triangle, Inc.

(HCTI) is the more profitable company, earning -51. 0% net margin versus -57. 2% for Health Catalyst, Inc. — meaning it keeps -51. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HCTI leads at -40. 6% versus -51. 7% for HCAT. At the gross margin level — before operating expenses — HCAT leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Health Catalyst, Inc.

(HCAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCAT: -95. 9%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.